110 related articles for article (PubMed ID: 6142319)
1. Successful treatment of metastatic glucagonoma with dacarbazine.
Kurose T; Seino Y; Ishida H; Fujita J; Taminato T; Matsukura M; Imura H
Lancet; 1984 Mar; 1(8377):621-2. PubMed ID: 6142319
[No Abstract] [Full Text] [Related]
2. [Metastatic glucagonoma. Complete remission by dacarbazine (5 years' recession)].
Jeanmougin M; Civatte J; Bonvalet D; Passa P; Verola O; Zylberait D
Ann Dermatol Venereol; 1988; 115(8):833-8. PubMed ID: 2849362
[No Abstract] [Full Text] [Related]
3. Unsuccessful DTIC treatment of a patient with glucagonoma syndrome.
Hallengren B; Dymling JF; Manhem P; Tennvall L; Tibblin S
Acta Med Scand; 1983; 213(4):317-8. PubMed ID: 6310975
[TBL] [Abstract][Full Text] [Related]
4. Glucagonoma and dacarbazine.
Duncan LA; Marynick SP
Ann Intern Med; 1982 Dec; 97(6):930. PubMed ID: 6293359
[No Abstract] [Full Text] [Related]
5. Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature.
Rosenbaum A; Flourie B; Chagnon S; Blery M; Modigliani R
Digestion; 1989; 42(2):116-20. PubMed ID: 2548911
[TBL] [Abstract][Full Text] [Related]
6. Malignant glucagonoma syndrome: response to chemotherapy.
Marynick SP; Fagadau WR; Duncan LA
Ann Intern Med; 1980 Sep; 93(3):453-4. PubMed ID: 6254416
[TBL] [Abstract][Full Text] [Related]
7. Response of glucagonoma syndrome to lomustine.
Khandekar JD; Sriratana P
Cancer Treat Rep; 1986 Mar; 70(3):433-4. PubMed ID: 3006914
[No Abstract] [Full Text] [Related]
8. The glucagonoma syndrome.
Sonksen PH; Bloom SR
J R Soc Med; 1990 Feb; 83(2):127. PubMed ID: 1969482
[No Abstract] [Full Text] [Related]
9. The glucagonoma syndrome.
Bloom SR; Sonksen PH
J R Soc Med; 1990 Jan; 83(1):60. PubMed ID: 1968103
[No Abstract] [Full Text] [Related]
10. Vipoma, glucagonoma and the role of Sandostatin.
Bloom SR
NATNEWS; 1989 Jul; 26(7):15. PubMed ID: 2550822
[No Abstract] [Full Text] [Related]
11. Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995.
Boden G; Ryan IG; Eisenschmid BL; Shelmet JJ; Owen OE
N Engl J Med; 1986 Jun; 314(26):1686-9. PubMed ID: 2872592
[No Abstract] [Full Text] [Related]
12. Glucagonoma and its angiographic diagnosis.
Wawrukiewicz AS; Rösch J; Keller FS; Lieberman DA
Cardiovasc Intervent Radiol; 1982; 5(6):318-24. PubMed ID: 6301675
[TBL] [Abstract][Full Text] [Related]
13. Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome.
Altimari AF; Bhoopalam N; O'Dorsio T; Lange CL; Sandberg L; Prinz RA
Surgery; 1986 Dec; 100(6):989-96. PubMed ID: 2878500
[TBL] [Abstract][Full Text] [Related]
14. DTIC therapy in patients with malignant intra-abdominal neuroendocrine tumors.
Altimari AF; Badrinath K; Reisel HJ; Prinz RA
Surgery; 1987 Dec; 102(6):1009-17. PubMed ID: 2825370
[TBL] [Abstract][Full Text] [Related]
15. Dimethyltriazenoimidazole carboxamide therapy of islet cell carcinoma of the pancreas.
Awrich AE; Peetz M; Fletcher WS
J Surg Oncol; 1981; 17(4):321-6. PubMed ID: 6267376
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin analogue and tissue cultures in the study of a human malignant glucagonoma.
Ahlman H; Ahlund L; Dahlström A; Grimelius L; Theodorsson E
J Surg Oncol; 1990 Jul; 44(3):191-9. PubMed ID: 2164620
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin analogue in treatment of coexisting glucagonoma and pancreatic pseudocyst: dissociation of responses.
Moattari AR; Cho K; Vinik AI
Surgery; 1990 Sep; 108(3):581-7. PubMed ID: 2168587
[TBL] [Abstract][Full Text] [Related]
18. Hepatic tumors with hyperglucagonemia. Response to treatment with human lymphoblastoid interferon.
Sheehan-Dare RA; Simmons AV; Cotterill JA; Janke PG
Cancer; 1988 Sep; 62(5):912-4. PubMed ID: 2842025
[TBL] [Abstract][Full Text] [Related]
19. Cytoreduction surgery for metastatic glucagonoma. A clinicopathologic study with special reference to the utility of immunocytochemistry and ultrastructure in diagnosis.
Rader DL; Martin JK; Scheithauer BW
Minn Med; 1984 Sep; 67(9):483-5, 516. PubMed ID: 6092886
[No Abstract] [Full Text] [Related]
20. Effect of somatostatin on skin lesions and concentrations of plasma amino acids in a patient with glucagonoma-syndrome.
Schmid R; Allescher HD; Schepp W; Hölscher A; Siewert R; Schusdziarra V; Classen M
Hepatogastroenterology; 1988 Feb; 35(1):34-7. PubMed ID: 2896149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
